KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) Net Income towards Common Stockholders (2016 - 2025)

Edwards Lifesciences has reported Net Income towards Common Stockholders over the past 17 years, most recently at $27.0 million for Q4 2025.

  • Quarterly results put Net Income towards Common Stockholders at $27.0 million for Q4 2025, down 31.3% from a year ago — trailing twelve months through Dec 2025 was $13.4 million (down 99.52% YoY), and the annual figure for FY2025 was $13.4 million, down 99.52%.
  • Net Income towards Common Stockholders for Q4 2025 was $27.0 million at Edwards Lifesciences, up from -$2.0 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for EW hit a ceiling of $2.7 billion in Q3 2024 and a floor of -$7.2 million in Q1 2025.
  • Median Net Income towards Common Stockholders over the past 5 years was $194.7 million (2021), compared with a mean of $314.6 million.
  • Biggest five-year swings in Net Income towards Common Stockholders: soared 5447.75% in 2024 and later tumbled 540.0% in 2025.
  • Edwards Lifesciences' Net Income towards Common Stockholders stood at $335.3 million in 2021, then rose by 18.82% to $398.4 million in 2022, then crashed by 90.81% to $36.6 million in 2023, then grew by 7.38% to $39.3 million in 2024, then plummeted by 31.3% to $27.0 million in 2025.
  • The last three reported values for Net Income towards Common Stockholders were $27.0 million (Q4 2025), -$2.0 million (Q3 2025), and -$4.4 million (Q2 2025) per Business Quant data.